Brandon Folkes
Stock Analyst at H.C. Wainwright
(1.00)
# 3,927
Out of 5,044 analysts
549
Total ratings
39%
Success rate
-0.7%
Average return
Main Sectors:
Stocks Rated by Brandon Folkes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $7 | $0.87 | +704.60% | 21 | Oct 8, 2026 | |
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $11 | $0.799 | +1,276.72% | 13 | Oct 6, 2026 | |
| SGMT Sagimet Biosciences | Reiterated: Buy | $29 | $8.93 | +224.75% | 13 | Oct 5, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | $15.63 | $10.63 | +47.05% | 19 | Oct 1, 2026 | |
| ENTA Enanta Pharmaceuticals | Reiterated: Buy | $20 | $12.50 | +60.00% | 13 | Sep 23, 2026 | |
| ANIP ANI Pharmaceuticals | Reiterated: Buy | $121 | $73.89 | +63.76% | 24 | Sep 21, 2026 | |
| COLL Collegium Pharmaceutical | Reiterated: Buy | $60 | $22.09 | +171.62% | 42 | Sep 21, 2026 | |
| DERM Journey Medical | Reiterated: Buy | $13 | $6.31 | +106.02% | 10 | Sep 21, 2026 | |
| MIST Milestone Pharmaceuticals | Reiterated: Buy | $8 | $0.765 | +945.75% | 17 | Sep 21, 2026 | |
| MNKD MannKind | Reiterated: Buy | $10 | $3.29 | +203.95% | 26 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.794 | +907.56% | 10 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.08 | +177.78% | 21 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $13.19 | +81.96% | 15 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12.82 | $1.78 | +620.43% | 15 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $5.78 | +211.42% | 10 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $10.48 | -4.58% | 9 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $11.39 | +128.27% | 16 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.4452 | +124.62% | 5 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.4061 | - | 40 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $7.38 | +76.15% | 13 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $20.50 | +192.68% | 7 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $19.83 | +66.41% | 26 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $5.07 | +156.41% | 11 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.11 | +373.93% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $7.41 | +61.94% | 14 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $35.83 | +33.97% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $200 | $3.90 | n/a | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $7.89 | n/a | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 → $16 | $7.06 | n/a | 29 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $4 | $2.30 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $10 | $0.8231 | n/a | 2 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 3 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $37 → $33 | $0.97 | n/a | 18 | Mar 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $15 | $2.46 | n/a | 15 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $238.55 | n/a | 1 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $40 | $0.539 | n/a | 2 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.0008 | n/a | 1 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $50 | $0.012 | n/a | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $32 | $40.61 | n/a | 12 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $25 | $36.13 | n/a | 3 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 | $218.42 | n/a | 10 | Oct 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $8 | $0.000001 | n/a | 4 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $35.07 | n/a | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $12 | $9.60 | n/a | 9 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $33 | $19.37 | n/a | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $30 | $38.30 | n/a | 2 | Sep 12, 2016 |
Connect Biopharma Holdings
Oct 8, 2026
Reiterated: Buy
Price Target: $7
Current: $0.87
Upside: +704.60%
Rani Therapeutics Holdings
Oct 6, 2026
Reiterated: Buy
Price Target: $11
Current: $0.799
Upside: +1,276.72%
Sagimet Biosciences
Oct 5, 2026
Reiterated: Buy
Price Target: $29
Current: $8.93
Upside: +224.75%
Eupraxia Pharmaceuticals Inc.
Oct 1, 2026
Reiterated: Buy
Price Target: $15.63
Current: $10.63
Upside: +47.05%
Enanta Pharmaceuticals
Sep 23, 2026
Reiterated: Buy
Price Target: $20
Current: $12.50
Upside: +60.00%
ANI Pharmaceuticals
Sep 21, 2026
Reiterated: Buy
Price Target: $121
Current: $73.89
Upside: +63.76%
Collegium Pharmaceutical
Sep 21, 2026
Reiterated: Buy
Price Target: $60
Current: $22.09
Upside: +171.62%
Journey Medical
Sep 21, 2026
Reiterated: Buy
Price Target: $13
Current: $6.31
Upside: +106.02%
Milestone Pharmaceuticals
Sep 21, 2026
Reiterated: Buy
Price Target: $8
Current: $0.765
Upside: +945.75%
MannKind
Sep 21, 2026
Reiterated: Buy
Price Target: $10
Current: $3.29
Upside: +203.95%
Sep 21, 2026
Reiterated: Buy
Price Target: $8
Current: $0.794
Upside: +907.56%
Sep 21, 2026
Reiterated: Buy
Price Target: $3
Current: $1.08
Upside: +177.78%
Sep 21, 2026
Reiterated: Buy
Price Target: $24
Current: $13.19
Upside: +81.96%
Sep 21, 2026
Reiterated: Buy
Price Target: $12.82
Current: $1.78
Upside: +620.43%
Sep 21, 2026
Reiterated: Buy
Price Target: $18
Current: $5.78
Upside: +211.42%
Sep 21, 2026
Reiterated: Buy
Price Target: $10
Current: $10.48
Upside: -4.58%
Sep 21, 2026
Reiterated: Buy
Price Target: $26
Current: $11.39
Upside: +128.27%
Aug 18, 2026
Reiterated: Hold
Price Target: $1
Current: $0.4452
Upside: +124.62%
Aug 17, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.4061
Upside: -
Aug 14, 2026
Reiterated: Buy
Price Target: $13
Current: $7.38
Upside: +76.15%
Aug 14, 2026
Reiterated: Buy
Price Target: $60
Current: $20.50
Upside: +192.68%
Aug 13, 2026
Reiterated: Buy
Price Target: $33
Current: $19.83
Upside: +66.41%
Aug 13, 2026
Reiterated: Buy
Price Target: $13
Current: $5.07
Upside: +156.41%
Aug 13, 2026
Reiterated: Buy
Price Target: $10
Current: $2.11
Upside: +373.93%
Aug 11, 2026
Reiterated: Buy
Price Target: $12
Current: $7.41
Upside: +61.94%
Aug 4, 2026
Reiterated: Buy
Price Target: $48
Current: $35.83
Upside: +33.97%
Mar 4, 2025
Reiterated: Buy
Price Target: $8 → $200
Current: $3.90
Upside: n/a
Nov 14, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $7.89
Upside: n/a
Aug 22, 2024
Initiated Coverage: Buy
Price Target: $23 → $16
Current: $7.06
Upside: n/a
May 3, 2024
Reiterated: Buy
Price Target: $3 → $4
Current: $2.30
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $20 → $10
Current: $0.8231
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 13, 2023
Reiterated: Hold
Price Target: $37 → $33
Current: $0.97
Upside: n/a
Feb 9, 2023
Reiterated: Buy
Price Target: $22 → $15
Current: $2.46
Upside: n/a
Feb 3, 2023
Reiterated: Buy
Price Target: $48
Current: $238.55
Upside: n/a
Nov 22, 2022
Reiterated: Buy
Price Target: $22 → $40
Current: $0.539
Upside: n/a
Nov 2, 2022
Initiated Coverage: Buy
Price Target: $5
Current: $0.0008
Upside: n/a
Mar 31, 2022
Reiterated: Buy
Price Target: $5 → $50
Current: $0.012
Upside: n/a
Jan 27, 2022
Upgraded: Buy
Price Target: $22 → $32
Current: $40.61
Upside: n/a
Nov 4, 2021
Reiterated: Buy
Price Target: $23 → $25
Current: $36.13
Upside: n/a
Oct 6, 2021
Reiterated: Buy
Price Target: $210
Current: $218.42
Upside: n/a
Aug 9, 2021
Reiterated: Buy
Price Target: $6 → $8
Current: $0.000001
Upside: n/a
Jun 30, 2021
Initiated Coverage: Buy
Price Target: $45
Current: $35.07
Upside: n/a
May 6, 2021
Reiterated: Buy
Price Target: $18 → $12
Current: $9.60
Upside: n/a
Dec 15, 2020
Reiterated: Buy
Price Target: $25 → $33
Current: $19.37
Upside: n/a
Sep 12, 2016
Reiterated: Buy
Price Target: $34 → $30
Current: $38.30
Upside: n/a